| 1 day |
| -0.82% | |||
| 1 week |
| -2.19% | |||
| 4 week |
| -3.52% | |||
| 3 month |
| -1.23% | |||
| YTD |
| -3.52% | |||
| 1 year | +20.98% |
| |||
| 3 years* |
| -10.61% | |||
| 5 years* |
| -1.08% | |||
| *annualized | |||||
| Best 3 month return | +22.78% | |
| Worst 3 month return | -42.46% |
| Return | Risk | Rating | |
| 3 years | - | - |
|
| 5 years | - | - |
|
| 10 years | - | - | - |
| Overall | - | - |
|
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
| Total assets | 18.34M | |
| Front load | - | |
| Deferred load | - | |
| Expense ratio | 2.33% | |
| Management fee | - | |
| Fund family | Marketocracy Funds |
| Cash | 23.91% | |
| Stocks | 68.88% | |
| Bonds | 2.10% | |
| Preferred | 1.07% | |
| Other | 4.03% |
| Initial | $2,000 | |
| Additional | $50 | |
| IRA Initial | $2,000 | |
| AIP Initial | $50 | |
| AIP Additional | $50 |
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | -2.90 | -3.23 | -0.44 | - | |
| Beta* | 0.75 | 0.96 | 1.01 | - | |
| Mean annual return | 1.70 | -0.70 | 0.09 | - | |
| R-squared* | 89.29 | 71.07 | 65.08 | - | |
| Standard deviation | 16.12 | 22.84 | 20.17 | - | |
| Sharpe ratio | 1.26 | -0.46 | -0.09 | - | |
| * Against standard index | |||||
| Security | Net Assets | |
| HighMark Diversified Money Market Fid | 8.72% | |
| HighMark 100% US Treasury MMkt Fid | 8.72% | |
| Endo Pharmaceutical Holdings, Inc. (ENDP) | 3.37% | |
| Myriad Pharmaceuticals, Inc. (MYRX) | 2.86% | |
| Pain Therapeutics, Inc. (PTIE) | 2.62% | |
| Southwestern Energy Company (SWN) | 2.53% | |
| Apple, Inc. (AAPL) | 2.28% | |
| PowerShares DB Gold Double Short ETN | 2.23% | |
| UltraShort Russell2000 ProShares | 2.22% | |
| Gladstone Investment Corporation (GAIN) | 2.16% |